To bring the treatment to the United States for further research, Orphan Pharmaceuticals U.S., with the help of the Poison Center, has applied to the FDA to test it. The process could take several years, but the end result may offer a safer and more effective treatment option for victims of scorpion stings in the United States. FDA approval also will help Bioclon in sharing their product with the rest of the world. Reaching only an inch and a half at maturity, it is a comparatively small scorpion. Scorpions are relatively inactive during the daylight hours with the majority of scorpion stings occurring at night during the warm summer months.
Scorpion stings can cause immediate local pain with minimal swelling.
Numbness and tingling are frequently reported. Small children are at highest risk. Stings occurring in children or any patient experiencing severe symptoms should be seen at a health care facility immediately.